{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-02T18:57:49.846874+00:00","company":{"ticker":"ONCY","cik":1129928,"company_name":"ONCOLYTICS BIOTECH INC"},"pagination":{"limit":100,"returned":4,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","facts":[{"fact_type":"executive_change","fact_key":"899e3fdee0","cik":1129928,"ticker":"ONCY","company_name":"ONCOLYTICS BIOTECH INC","filed_at":"2026-06-02T13:02:48+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2026-06-01","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Stephen Glover was appointed as Director at ONCOLYTICS BIOTECH INC.","evidence_excerpt":"appointed Stephen Glover as the ninth director of the Board","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001129928-26-000039","anchor_url":"https://secwatch.observer/filing/0001129928-26-000039#claim-899e3fdee0","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1129928/000112992826000039/0001129928-26-000039-index.htm"},{"fact_type":"executive_change","fact_key":"51d737ca37","cik":1129928,"ticker":"ONCY","company_name":"ONCOLYTICS BIOTECH INC","filed_at":"2026-06-02T13:02:48+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2026-06-01","interim":false,"role":"Chief Operating Officer","role_category":"coo","successor_name":null,"successor_named":false},"claim":"John McAdory was appointed as Chief Operating Officer at ONCOLYTICS BIOTECH INC.","evidence_excerpt":"appointed John McAdory as Chief Operating Officer of the Company","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001129928-26-000039","anchor_url":"https://secwatch.observer/filing/0001129928-26-000039#claim-51d737ca37","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1129928/000112992826000039/0001129928-26-000039-index.htm"},{"fact_type":"governance_change","fact_key":"c9a1968f6ba4a562a9a0f9cb6664050d1699ac5d","cik":1129928,"ticker":"ONCY","company_name":"ONCOLYTICS BIOTECH INC","filed_at":"2026-04-01T23:59:59+00:00","payload":{"change_type":"bylaw_amendment","effective_date":null,"item_codes_triggered":["5.03"],"summary_text":"Filed Articles of Incorporation and adopted Bylaws in connection with domestication from British Columbia to Nevada."},"claim":"ONCOLYTICS BIOTECH INC: Filed Articles of Incorporation and adopted Bylaws in connection with domestication from British Columbia to Nevada.","evidence_excerpt":"On the Effective Date and in connection with the Domestication, the Company filed with the Nevada Secretary of State: (i) the Articles of Domestication of Oncolytics Biotech Inc. (the “Articles of Domestication”); and (ii) the Articles of Incorporation of Oncolytics Biotech Inc. (the “Articles of Incorporation”). In addition, the Company adopted bylaws (the “Bylaws”), which became effective on the Effective Date.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-26-038272","anchor_url":"https://secwatch.observer/filing/0001104659-26-038272#claim-c9a1968f6ba4a562a9a0f9cb6664050d1699ac5d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1129928/000110465926038272/0001104659-26-038272-index.htm"},{"fact_type":"governance_change","fact_key":"fa6fd44d4cfd74b8b7e4b9f51b1d35a6f9142ed2","cik":1129928,"ticker":"ONCY","company_name":"ONCOLYTICS BIOTECH INC","filed_at":"2026-03-20T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":null,"item_codes_triggered":["5.03"],"summary_text":"Adopted continuation application with new Notice of Articles and Articles of Oncolytics British Columbia, changing governing documents from Alberta to British Columbia corporate law."},"claim":"ONCOLYTICS BIOTECH INC: Adopted continuation application with new Notice of Articles and Articles of Oncolytics British Columbia, changing governing documents from Alberta to British Columbia corporate law.","evidence_excerpt":"In connection with the consummation of the Continuance, the Company adopted a continuation application, which contained the Notice of Articles of Oncolytics British Columbia (the “Notice of Articles”) and the Articles of Oncolytics British Columbia (the “Articles”)","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-26-032763","anchor_url":"https://secwatch.observer/filing/0001104659-26-032763#claim-fa6fd44d4cfd74b8b7e4b9f51b1d35a6f9142ed2","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1129928/000110465926032763/0001104659-26-032763-index.htm"}]}